Phase II Study of Dose-Dense TC (Docetaxel + Cyclophosphamide) With Pegfilgrastim Support for Adjuvant Therapy of pN0, pN1 or Nx Breast Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Pegfilgrastim (Primary) ; Cyclophosphamide; Docetaxel
- Indications Breast cancer
- Focus Adverse reactions
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Aug 2012 New trial record